Okita, Riki <br/><br/>
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  May 2016 
 - 499-509 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-016-1814-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Ataxia Telangiectasia Mutated Proteins--genetics<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>Female<br/>Histocompatibility Antigens Class I--biosynthesis<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Killer Cells, Natural--drug effects<br/>Lung Neoplasms--genetics<br/>Male<br/>Middle Aged<br/>Prognosis<br/>RNA Interference<br/>Signal Transduction--drug effects<br/>Up-Regulation--genetics